Day One Biopharmaceuticals Inc Equity to Assets Ratio 2 year CAGR is -3.52% for the Trailing 12 Months (TTM) ending March 31, 2024. The Equity to Assets Ratio measures the proportion of a company's total assets that are financed by equity. It provides insight into the company's financial stability and the percentage of assets owned by shareholders. A higher ratio indicates a greater ownership stake by equity shareholders and suggests lower financial risk. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.